Biotech Values

[DewDiligence]

MON probably gained market share vs DD recently:

http://finance.yahoo.com/news/dupont-lowers-operating-earnings-outlook-200500672.html

Today DuPont announced that the company is revising its outlook for operating earnings per share for the second quarter and full year 2014, due primarily to lower than expected quarterly performance of its Agriculture and, to a lesser extent, Performance Chemicals segments.

Both companies are reporting soft corn sales, but MON—unlike DD—is making up the difference with strong soybean sales, especially in South America, where the Intacta product is having a very strong rollout.

(Note: It’s hard to make a direct timing comparison between MON and DD because they operate on different fiscal calendars. MON’s quarterly results announced this week were for the period ending 5/31/14, while DD’s lowered guidance is for the quarter ending 6/30/14.)